Literature DB >> 2784442

Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement.

H C Amstutz1, D A Friscia, F Dorey, B T Carney.   

Abstract

Between 1970 and 1987, 3000 total hip replacements were performed at the University of California at Los Angeles, and all patients were given warfarin prophylactically, in conjunction with early postoperative elevation of the lower limb in balanced suspension and the application of elastic hose. Since 1973, the first dose of warfarin has been given on the night of the operation, and the prothrombin time has been maintained between sixteen and eighteen seconds. A pulmonary embolism occurred after fourteen (0.5 per cent) of the 3000 operations. It was never fatal. Bleeding occurred after forty-four operations (1.5 per cent). The effectiveness of the protocol of the University of California at Los Angeles was demonstrated in a large number of patients over a seventeen-year period. Since 1974, the protocol has included closer monitoring of the prothrombin time. After 2595 hip replacements that were done between 1974 and 1987, the rate of pulmonary embolism was 0.2 per cent and the rate of bleeding complications was 1.0 per cent. However, recently a higher incidence of bleeding complications (2.3 per cent) has been noted after non-cemented total hip (stem-type) replacement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784442

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  6 in total

1.  Fatal pulmonary embolism following conservatively managed tendo achilles rupture-A case report.

Authors:  S Venkatachalam; K U Wright
Journal:  Int J Surg Case Rep       Date:  2011-10-08

2.  Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.

Authors:  A Planes; N Vochelle; J Y Darmon; M Fagola; M Bellaud; D Compan; E Saliba; N Weisslinger; Y Huet
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 3.  The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.

Authors:  D K Potyk; H J Tabbarah
Journal:  J Gen Intern Med       Date:  1993-04       Impact factor: 5.128

4.  The use of warfarin as thromboprophylaxis for lower limb arthroplasty.

Authors:  Mark R Dunbar; Piyush K Upadhyay; Shanmugam Karthikeyan
Journal:  Ann R Coll Surg Engl       Date:  2008-07-02       Impact factor: 1.891

5.  VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study.

Authors:  Alejandro González Della Valle; Saurabh Khakharia; Charles J Glueck; Nicole Taveras; Ping Wang; Robert N Fontaine; Eduardo A Salvati
Journal:  Clin Orthop Relat Res       Date:  2008-11-26       Impact factor: 4.176

6.  Screening for deep vein thrombosis after periacetabular osteotomy in adult patients: is it necessary?

Authors:  Gregory G Polkowski; Stephen T Duncan; Adam D Bloemke; Perry L Schoenecker; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2014-04-15       Impact factor: 4.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.